ctrl K

Price Alert

Armata Pharmaceuticals In... (ARMP)

AMEX: ARMP · Real-Time Price · USD

2.65

0.04 (1.53%)

At close: Aug 19, 2025, 1:32 PM

Armata Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	9.29M	13.52M	14.85M	10.29M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	5.48M	5.72M	5.96M	1.2M
Other Long-Term Assets	975K	2.47M	-9.61M	-8.28M
Receivables	744K	3.36M	1.94M	2.99M
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	1.27M	2.27M	6.59M	n/a
Total Current Assets	11.31M	19.15M	27.05M	14.99M
Property-Plant & Equipment	54.93M	57.28M	46.65M	38.07M
Goodwill & Intangibles	13.75M	13.75M	13.75M	13.75M
Total Long-Term Assets	75.13M	79.21M	68.79M	54.77M
Total Assets	86.44M	98.36M	95.83M	69.77M
Account Payables	766K	1.58M	1.68M	1.14M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	38.95M	9.48M	17.01M	1.51M
Other Current Liabilities	529K	-8.19M	-12.65M	-377K
Total Current Liabilities	48.25M	16.46M	24.87M	4.81M
Long-Term Debt	55.44M	82.31M	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	3.08M	3.08M
Total Long-Term Liabilities	86.21M	113.97M	34.88M	39.56M
Total Liabilities	134.46M	130.43M	59.75M	44.37M
Total Debt	126.52M	120.37M	48.81M	37.99M
Common Stock	362K	361K	361K	271K
Retained Earnings	-327.74M	-308.82M	-239.77M	-202.86M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	-48.02M	-32.06M	36.08M	25.4M
Total Investments	5.48M	5.72M	5.96M	1.2M